These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 6477749

  • 1. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
    Lepri E, Menconi E, Barzi AM.
    Boll Soc Ital Biol Sper; 1984 Jul 31; 60(7):1369-75. PubMed ID: 6477749
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
    Ramu N, Ramu A, Cole DE, Balis FM, Poplack DG, Pollard HB.
    Isr J Med Sci; 1988 Jul 31; 24(9-10):477-82. PubMed ID: 2974448
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
    Ganapathi R, Grabowski D.
    Cancer Res; 1983 Aug 31; 43(8):3696-9. PubMed ID: 6861140
    [Abstract] [Full Text] [Related]

  • 9. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
    Ramu A, Fuks Z, Gatt S, Glaubiger D.
    Cancer Res; 1984 Jan 31; 44(1):144-8. PubMed ID: 6690032
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Circumvention of drug resistance of P388/R cells by the combination of adriamycin and mitoxantrone with hyperthermia (42 degrees C).
    Juvekar AS, Chitnis MP.
    Neoplasma; 1991 Jan 31; 38(2):207-11. PubMed ID: 2041579
    [Abstract] [Full Text] [Related]

  • 12. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R, Reiter W, Krishan A.
    J Natl Cancer Inst; 1982 Jun 31; 68(6):1027-32. PubMed ID: 6953267
    [Abstract] [Full Text] [Related]

  • 13. Doxorubicin cytotoxicity to P388 lymphocytic leukemia as determined by alkaline elution and established assays.
    Russo P, Favoni RE, Zarcone D, Miglietta L, Peluso M, Nicolin A, Bignone F, Parodi S.
    Anticancer Res; 1986 Jun 31; 6(6):1297-304. PubMed ID: 3813486
    [Abstract] [Full Text] [Related]

  • 14. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
    Shinoda H, Inaba M, Tsuruo T.
    Cancer Res; 1989 Apr 01; 49(7):1722-6. PubMed ID: 2924316
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tyrosine and phenylalanine restriction sensitizes adriamycin-resistant P388 leukemia cells to adriamycin.
    Elstad CA, Thrall BD, Raha G, Meadows GG.
    Nutr Cancer; 1996 Apr 01; 25(1):47-60. PubMed ID: 8837861
    [Abstract] [Full Text] [Related]

  • 17. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1983 Jun 01; 43(6):2905-10. PubMed ID: 6850602
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
    Inaba M, Kobayashi H, Sakurai Y, Johnson RK.
    Cancer Res; 1979 Jun 01; 39(6 Pt 1):2200-3. PubMed ID: 445418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.